{"id":"W3125520517","doi":"10.1093/eurjpc/zwaa097","title":"Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Adverse effect; Statin; Familial hypercholesterolemia; Evolocumab; Tolerability; Cholesterol; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004342472,0.0001300199,0.0008497501,0.00007278701,0.00004292086,0.000005655237,0.0001630814,0.00002672202,0.000008878708],"category_scores_gemma":[0.0009966476,0.00008204607,0.0003460719,0.0001757711,0.0001100739,0.0000371153,0.0001311718,0.0004567197,0.000003507214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002567227,"about_ca_system_score_gemma":0.0001378448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009787561,"about_ca_topic_score_gemma":9.785402e-7,"domain_scores_codex":[0.9951343,0.003450167,0.0007762122,0.0001937105,0.0002697264,0.0001759115],"domain_scores_gemma":[0.9988239,0.0001449837,0.0003984677,0.000261953,0.0001723339,0.0001983938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02341682,0.001768283,0.5414275,0.001163508,0.01641968,0.01981465,0.06820696,0.002393187,0.0061726,0.0004585468,0.004942743,0.3138155],"study_design_scores_gemma":[0.008056764,0.002518088,0.9798933,0.0001150326,0.0004432824,0.0005322442,0.003341613,0.0000147993,0.00003120115,0.000005806423,0.004967853,0.00008004429],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904988,0.00253587,0.001586159,0.00154828,0.0001005384,0.000659437,0.000003619977,0.000006819067,0.003060522],"genre_scores_gemma":[0.9978701,0.00102272,0.0001409713,0.0003106913,0.0006114633,0.000001168988,0.000001329706,0.00002224805,0.00001930182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4384657,"threshold_uncertainty_score":0.3345742,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02503213564825833,"score_gpt":0.2839644164855822,"score_spread":0.2589322808373239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}